GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Revenue

Sinopharm Tech Holdings (HKSE:08156) Revenue : HK$46.66 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Revenue?

Sinopharm Tech Holdings's revenue for the three months ended in Dec. 2023 was HK$14.85 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$46.66 Mil. Sinopharm Tech Holdings's Revenue per Share for the three months ended in Dec. 2023 was HK$0.08. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.26.

Warning Sign:

Sinopharm Tech Holdings Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Sinopharm Tech Holdings was 3.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -38.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Sinopharm Tech Holdings's highest 3-Year average Revenue per Share Growth Rate was 70.50% per year. The lowest was -48.30% per year. And the median was -13.60% per year.


Sinopharm Tech Holdings Revenue Historical Data

The historical data trend for Sinopharm Tech Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Revenue Chart

Sinopharm Tech Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.50 165.93 77.81 40.99 42.84

Sinopharm Tech Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.40 4.73 23.09 3.99 14.85

Competitive Comparison of Sinopharm Tech Holdings's Revenue

For the Software - Application subindustry, Sinopharm Tech Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's Revenue Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's Revenue falls into.



Sinopharm Tech Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$46.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Tech Holdings  (HKSE:08156) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sinopharm Tech Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines